| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |